Condition

Adult-Onset Still's Disease

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's DiseaseNCT07151157 · 2025-08-30

ACTIVE_NOT_RECRUITING

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)NCT05432960 · 2023-12-01

WITHDRAWN

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized StudyNCT01033656 · 2005-12-01

COMPLETED

Common interventions

add-on sirolimus therapyDRUG1anakinraDRUG1comparatorsDRUG1PlaceboDRUG1RPH-104BIOLOGICAL1

Leading sponsors

R-Pharm International, LLC1Ruijin Hospital1University of Helsinki1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

WITHDRAWN1

Phase mix

NA1

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.